Categories: Alternative Medicine

Agreement for Commercialisation of an Ayurvedic Formulation for Treatment of Malaria and an Ayurvedic Formulation for Treatment of Diabetes

New Delhi, February 20, 2016: National Research Development Corporation (NRDC), an Enterprise of the Department of Scientific & Industrial Research, Ministry of Science & Technology, Govt. of India, New Delhi and M/s Dabur India Ltd., New Delhi have entered into License Agreements for commercialization of Ayush-64, an ayurvedic formulation for treatment of Malaria and Ayush-82, an ayurvedic Formulation for management of Diabetes both developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an Autonomous body of the Ministry of AYUSH (Ayurveda, Yoga and naturopathy, Unani, Siddha and Homeopathy). The Licence agreements were signed by Dr. H. Purushotham on behalf of National Research Development Corporation, New Delhi and Dr. J. L. N. Sastry, Head Healthcare Research, on behalf of Dabur India Ltd., New Delhi at NRDC Office in the presence of Sh. B.N. Sarkar, Scientist (F), Department of Scientific and Industrial Research, New Delhi and Director, NRDC Board and other Senior executives of NRDC and Dabur. The Agreements were exchanged in the presence of the Minister of State, Ministry of AYUSH, Shri Shripad Yesso Naik and Secretary AYUSH, Shri Ajit M. Sharan, NRDC a Government Technology Licensing Agency has so far licensed about 10 technologies developed by CCRAS to more than 30 companies in India.

The Ayurvedic Drug Ayush-64 is very effective for the treatment of Malaria which is one of the most prevalent; destructive widely spread disease, well known to Ayurvedic Physicians as Visama Jvara from ancient times. In view of its wide prevalence and drug resistant malarial parasite, a poly-herbal non-toxic drug has been developed by CCRAS after carrying out extensive pharmacological, toxicological and Clinical studies.

Ayush-82 ; an anti diabetic drug also developed by CCRAS is a combination of known and tested hypoglycemic drugs

The use of these two drugs would help millions of people suffering from Malaria and Diabetes.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

2 days ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

2 days ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

3 days ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

3 days ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

4 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

4 days ago